Replimune Group (NASDAQ:REPL) Price Target Raised to $17.00

Replimune Group (NASDAQ:REPL – Free Report) had its target price raised by JPMorgan Chase & Co. from $14.00 to $17.00 in a report published on Tuesday morning, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. Several other research firms have also recently weighed in on REPL. Roth Mkm began […]

Leave a Reply

Your email address will not be published.

Previous post Sunrun (NASDAQ:RUN) Stock Rating Reaffirmed by The Goldman Sachs Group
Next post Rosenblatt Securities Reiterates “Buy” Rating for Ribbon Communications (NASDAQ:RBBN)